Healthcor Management LP Has Decreased Its Stake in Laboratory Corp Amer Hldgs (LH) by $75.09 Million as Stock Rose

May 18, 2018 - By Karen Cook

Laboratory Corporation of America Holdings (NYSE:LH) LogoInvestors sentiment increased to 1.2 in 2017 Q4. Its up 0.30, from 0.9 in 2017Q3. It increased, as 36 investors sold LH shares while 209 reduced holdings. 73 funds opened positions while 220 raised stakes. 91.47 million shares or 0.35% less from 91.79 million shares in 2017Q3 were reported. Indiana Tru And Inv Co reported 0.1% in Laboratory Corporation of America Holdings (NYSE:LH). Teachers Retirement System Of The State Of Kentucky has 0.26% invested in Laboratory Corporation of America Holdings (NYSE:LH) for 140,028 shares. Champlain Prtnrs Lc accumulated 763,390 shares. Exxonmobil Invest Tx has invested 0.07% in Laboratory Corporation of America Holdings (NYSE:LH). Wetherby Asset holds 0.03% of its portfolio in Laboratory Corporation of America Holdings (NYSE:LH) for 1,468 shares. Liberty Mutual Group Inc Inc Asset Mgmt Inc owns 4,057 shares. Davenport And Limited Com holds 0.01% or 4,623 shares. Franklin Resource, a California-based fund reported 508,311 shares. Oppenheimer Asset Management has 0.01% invested in Laboratory Corporation of America Holdings (NYSE:LH) for 1,484 shares. Sentry Invs Corp stated it has 1.68% of its portfolio in Laboratory Corporation of America Holdings (NYSE:LH). Rockefeller Serv holds 0% or 134 shares. Moreover, Davidson Investment Advsr has 1.15% invested in Laboratory Corporation of America Holdings (NYSE:LH). Quantitative Systematic Strategies Ltd Liability Corp stated it has 0.14% in Laboratory Corporation of America Holdings (NYSE:LH). Global Thematic Partners Ltd Liability Company holds 3.58% or 680,829 shares. Conning holds 2,341 shares or 0.01% of its portfolio.

Since February 7, 2018, it had 0 insider purchases, and 5 insider sales for $18.70 million activity. The insider KING DAVID P sold $8.30 million. 8,400 Laboratory Corporation of America Holdings (NYSE:LH) shares with value of $1.41M were sold by EISENBERG GLENN A. 3,300 shares were sold by ANDERSON KERRII B, worth $548,124.

Arthur B Cohen decreased its stake in Laboratory Corp Amer Hldgs (LH) by 30.04% based on its latest 2017Q4 regulatory filing with the SEC. Healthcor Management Lp sold 472,290 shares as the company’s stock rose 1.25% while stock markets declined. The hedge fund run by Arthur B Cohen held 1.10 million shares of the medical specialities company at the end of 2017Q4, valued at $175.46 million, down from 1.57 million at the end of the previous reported quarter. Healthcor Management Lp who had been investing in Laboratory Corp Amer Hldgs for a number of months, seems to be less bullish one the $18.07B market cap company. The stock increased 0.18% or $0.32 during the last trading session, reaching $176.62. About 33,694 shares traded. Laboratory Corporation of America Holdings (NYSE:LH) has risen 14.17% since May 18, 2017 and is uptrending. It has outperformed by 2.62% the S&P500.

Healthcor Management Lp, which manages about $3.20B and $3.07 billion US Long portfolio, upped its stake in Medtronic Plc (NYSE:MDT) by 1.88 million shares to 1.95M shares, valued at $157.46 million in 2017Q4, according to the filing. It also increased its holding in Intuitive Surgical Inc (NASDAQ:ISRG) by 196,430 shares in the quarter, for a total of 221,470 shares, and has risen its stake in Merck & Co Inc (NYSE:MRK).

Analysts await Laboratory Corporation of America Holdings (NYSE:LH) to report earnings on July, 25. They expect $2.91 earnings per share, up 17.81 % or $0.44 from last year’s $2.47 per share. LH’s profit will be $297.69 million for 15.17 P/E if the $2.91 EPS becomes a reality. After $2.78 actual earnings per share reported by Laboratory Corporation of America Holdings for the previous quarter, Wall Street now forecasts 4.68 % EPS growth.

More important recent Laboratory Corporation of America Holdings (NYSE:LH) news were published by: Globenewswire.com which released: “New Research Coverage Highlights Internap, Dime Community Bancshares, Cohu, Laboratory Corporation of America …” on May 18, 2018, also Seekingalpha.com published article titled: “Laboratory of America Holdings (LH) Q1 2018 Results – Earnings Call Transcript”, Streetinsider.com published: “Glenview Capital Enters AmerisourceBergen (ABC), Express Scripts (ESRX), T-Mobile (TMUS) (more…) -13F” on May 15, 2018. More interesting news about Laboratory Corporation of America Holdings (NYSE:LH) was released by: Benzinga.com and their article: “Lab Stocks: Baird Favors Laboratory Corp., Says Quest Diagnostics Is The Simple Choice” with publication date: May 01, 2018.

Laboratory Corporation of America Holdings (NYSE:LH) Ratings Coverage

Among 14 analysts covering Laboratory Corp (NYSE:LH), 11 have Buy rating, 0 Sell and 3 Hold. Therefore 79% are positive. Laboratory Corp had 22 analyst reports since November 24, 2017 according to SRatingsIntel. Credit Suisse downgraded Laboratory Corporation of America Holdings (NYSE:LH) rating on Monday, December 11. Credit Suisse has “Hold” rating and $170.0 target. On Thursday, January 11 the stock rating was maintained by SunTrust with “Buy”. As per Thursday, March 1, the company rating was maintained by Credit Suisse. Craig Hallum maintained Laboratory Corporation of America Holdings (NYSE:LH) on Wednesday, February 7 with “Buy” rating. The company was maintained on Wednesday, February 28 by Morgan Stanley. Credit Suisse maintained Laboratory Corporation of America Holdings (NYSE:LH) rating on Thursday, March 8. Credit Suisse has “Outperform” rating and $195 target. The firm earned “Hold” rating on Friday, December 1 by Mizuho. As per Wednesday, January 24, the company rating was maintained by Mizuho. The firm earned “Outperform” rating on Tuesday, May 1 by Robert W. Baird. The firm has “Overweight” rating by Barclays Capital given on Monday, February 26.

Laboratory Corporation of America Holdings (NYSE:LH) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: